NADase
NADase structure
|
Common Name | NADase | ||
|---|---|---|---|---|
| CAS Number | 9032-65-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of NADaseNADase is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | DPN NUCLEOSIDASE |
|---|
| Description | NADase is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Storage condition | −20°C |
|---|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells.
J. Biol. Chem. 288(36) , 25938-49, (2013) NAD(+) is mainly synthesized in human cells via the "salvage" pathways starting from nicotinamide, nicotinic acid, or nicotinamide riboside (NR). The inhibition with FK866 of the enzyme nicotinamide p... |
|
|
A pre-steady state and steady state kinetic analysis of the N-ribosyl hydrolase activity of hCD157.
Arch. Biochem. Biophys. 564 , 156-63, (2014) hCD157 catalyzes the hydrolysis of nicotinamide riboside (NR) and nicotinic acid riboside (NAR). The release of nicotinamide or nicotinic acid from NR or NAR was confirmed by spectrophotometric, HPLC ... |
|
|
[Therapeutic monoclonal antibodies against multiple myeloma].
Nihon Rinsho. 73(1) , 119-23, (2015) Multiple myeloma (MM) remains mostly incurable despite the recent progress in the treatment strategy. One of novel fields for anti-MM therapeutic strategy is the development of immunotherapy using mon... |